The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial.
about
Beyond CD19: Opportunities for Future Development of Targeted Immunotherapy in Pediatric Relapsed-Refractory Acute LeukemiaCD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemiaA prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantationTacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT.A randomized phase II trial of tacrolimus, mycophenolate mofetil and sirolimus after non-myeloablative unrelated donor transplantation.Novel agents for the treatment of childhood acute leukemia.Graft-versus-host disease prophylaxis after transplantation: a network meta-analysis.Blood and marrow transplant clinical trials network state of the Science Symposium 2014New frontiers in pediatric Allo-SCT.IgH-V(D)J NGS-MRD measurement pre- and early post-allotransplant defines very low- and very high-risk ALL patients.Risk factors and timing of relapse after allogeneic transplantation in pediatric ALL: for whom and when should interventions be tested?Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research.Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen-Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic Malignancies.Murine allogeneic CD19 CAR T cells harbor potent antileukemic activity but have the potential to mediate lethal GVHD.The addition of sirolimus to the graft-versus-host disease prophylaxis regimen in reduced intensity allogeneic stem cell transplantation for lymphoma: a multicentre randomized trialPharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II.Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention.New frontiers in pediatric Allo-SCT: novel approaches for children and adolescents with ALL.Biological relevance of Hsp90-binding immunophilins in cancer development and treatment.The efficacy and safety of sirolimus-based graft-versus-host disease prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials.The Immunomodulatory and Therapeutic Effects of Mesenchymal Stromal Cells for Acute Lung Injury and Sepsis.Association of Minimal Residual Disease With Clinical Outcome in Pediatric and Adult Acute Lymphoblastic Leukemia: A Meta-analysis.New perspectives on the use of mTOR inhibitors in allogeneic haematopoietic stem cell transplantation and graft-versus-host disease.Association between C-reactive protein levels in the first 1-3 days post-transplant and allogeneic immune reactions.Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantationInfluence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.Outcomes of matched sibling donor bone marrow transplantation in children using single-agent calcineurin inhibitors as prophylaxis for graft versus host disease.A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114).Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy.Relapse post hematopoietic SCT remains the Achilles heel for the field.
P2860
Q26781328-F9F6C694-46FD-4622-9C97-C4E3B27F8711Q28084879-307FFC33-9046-415B-A697-7FF02CACF951Q33573529-B1DA329B-DAE8-427B-A7A0-44FA76499114Q34077792-08162BAF-D25D-47C0-8995-7F10DA34E463Q34272554-081A36DA-5D5C-470E-84E9-D04746A1251CQ35192790-6E09BC54-BF08-4E9C-93F7-BB7F2E3EFE32Q35499395-D32EFF6A-9892-479C-B3E1-2AB4AD01BF4DQ35591760-016A53A7-9799-4F9B-8A6A-8426C80D5ADDQ35628739-2D43CA59-E150-4DC6-A6B2-D6186961E781Q35662007-30FF3EA0-8804-4282-9778-E10B69B3F57DQ36069886-A9562B5F-5E74-460C-88E7-34908B7924EEQ36302281-93A495FA-0818-481D-B676-B5CBC994C08DQ36445665-1B853DD2-01EF-4EB2-A06C-CD420EC05A94Q36675086-3425E80A-8C7E-42BC-BBDC-0B4AF13C4C78Q36734547-CD1EB30B-9463-4033-9842-CC93EEEDE527Q36777485-073BC391-9046-401E-B101-439633046374Q36925951-D5D22F94-8BAA-4FFB-B8A2-45997A64996CQ38220573-6299B7EA-68A4-424F-818B-11BE61B16150Q38371280-61C51694-FC46-4791-8F45-8337F5DA5722Q38413246-07C3200F-0ACF-4C77-895F-D9F0252485B3Q38442767-612A6C38-6F4B-45B5-ADF3-6C532AC4A832Q38792016-099AD169-3AC7-4011-8FD7-78801C6E78F5Q38849186-CBFF3EC0-2683-4E20-BBFF-988181DB7EFDQ39006094-6F3B95CA-B74D-4A11-A3F5-91F8E2F8B22BQ39617623-77701999-2601-4000-80EC-80D65697F9B5Q45874732-794D8F7A-C778-4934-895A-6E8BF0E6F203Q47140612-1F293BE6-D991-4FA2-BF35-017F434A298EQ50799489-F3B21315-7B46-4AAA-AA36-4EDE876E5A6EQ52875784-26C4A53D-879C-4931-AE92-FCD287C78BDDQ53029398-CD506F47-40DF-44F1-9DA4-DC29D4602F22
P2860
The addition of sirolimus to tacrolimus/methotrexate GVHD prophylaxis in children with ALL: a phase 3 Children's Oncology Group/Pediatric Blood and Marrow Transplant Consortium trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The addition of sirolimus to t ...... w Transplant Consortium trial.
@en
The addition of sirolimus to t ...... w Transplant Consortium trial.
@nl
type
label
The addition of sirolimus to t ...... w Transplant Consortium trial.
@en
The addition of sirolimus to t ...... w Transplant Consortium trial.
@nl
prefLabel
The addition of sirolimus to t ...... w Transplant Consortium trial.
@en
The addition of sirolimus to t ...... w Transplant Consortium trial.
@nl
P2093
P2860
P50
P1433
P1476
The addition of sirolimus to t ...... ow Transplant Consortium trial
@en
P2093
Bryan Langholz
Candace Taylor
Denise Howrie
Donna A Wall
Elizabeth Raetz
James G Douglas
Julie M Gastier-Foster
Michael A Pulsipher
Michael Borowitz
Nancy Bunin
P2860
P304
P356
10.1182/BLOOD-2013-10-534297
P407
P577
2014-02-04T00:00:00Z